Target intelligence / Profile preview

Off-target messenger RNAs with partial complementarity to B7 homolog 3 (B7-H3) short hairpin RNA seed region

Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Off-target messenger RNAs with partial complementarity to B7 homolog 3 (B7-H3) short hairpin RNA (shRNA) seed region refer to a diverse set of unintended genetic transcripts that are downregulated during the use of RNA interference (RNAi) tools directed against B7-H3 (CD276). This phenomenon is driven by the 'seed region' of the shRNA guide strand (nucleotides 2–8), which can bind to the 3' untranslated regions (UTRs) of non-target mRNAs with partial complementarity, mimicking the action of endogenous microRNAs (Jackson et al., 2003; Birmingham et al., 2006). B7-H3 is a member of the B7 family of immunoregulatory proteins and is a significant target in oncology due to its overexpression in various solid tumors and its role in inhibiting T-cell mediated immune responses (NCBI Gene ID: 80381). However, research utilizing shRNAs to knock down B7-H3 has often encountered 'off-target toxicity,' where the observed phenotypic changes—such as reduced cell proliferation or increased apoptosis—are actually caused by the unintended silencing of these off-target mRNAs rather than the loss of B7-H3 itself (Lin et al., 2019). This highlights a critical challenge in functional genomics and the development of RNAi-based therapeutics, necessitating rigorous validation through rescue experiments or the use of multiple independent shRNA sequences to ensure specificity. These off-target interactions are not therapeutic goals but represent technical artifacts that can lead to false-positive results in drug target validation studies.

Other names
Seed-sequence-dependent off-targetsRNAi off-target effectsmiRNA-like off-target silencingB7-H3 shRNA off-targets
02

Mechanism of action

Unintended sequence-specific downregulation of mRNAs via the RNA-induced silencing complex (RISC) triggered by seed-region complementarity in the 3' UTR.

03

Biological functions

Post-transcriptional gene silencingRNA interference
04

Disease associations

Off-target toxicityExperimental artifact
05

Safety considerations

Unintended gene silencingOff-target toxicityConfounding experimental resultsFalse positive phenotypes
06

Interacting drugs

B7-H3 short hairpin RNA
07

Biomarkers

Transcriptome-wide expression profilingRNA-seqDual-luciferase reporter assays

Beyond the preview

Go deeper on Off-target messenger RNAs with partial complementarity to B7 homolog 3 (B7-H3) short hairpin RNA seed region.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target messenger RNAs with partial complementarity to B7 homolog 3 (B7-H3) short hairpin RNA seed region.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call